Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novartis AG (NYSE:NVS)

80.63
Delayed Data
As of May 26
 -0.72 / -0.89%
Today’s Change
66.93
Today|||52-Week Range
83.58
+10.69%
Year-to-Date
Intercept's (ICPT) Liver Drug Ocaliva Approved in Canada
May 29 / Zacks.com - Paid Partner Content
Perrigo, Taro Show Perils of Failure to Branch in Branded Drugs
May 23 / TheStreet.com - Paid Partner Content
Kite Pharma Cancer Drug BLA Gets Priority Review Status
May 29 / Zacks.com - Paid Partner Content
Here's Why Alexion Pharma (ALXN) Stock is Sinking Today
May 23 / Zacks.com - Paid Partner Content
Dodge & Cox Buys Express Scripts, Bristol-Myers, HP
May 25 / GuruFocus News - Paid Partner Content
Novartis' (NVS) Lung Cancer Drug Gets Positive CHMP Opinion
May 22 / Zacks.com - Paid Partner Content
Alnylam Pharmaceuticals (ALNY) Progressing Well on Pipeline
May 25 / Zacks.com - Paid Partner Content
Amgen (AMGN) Submits BLA to FDA for Migraine Drug Erenumab
May 19 / Zacks.com - Paid Partner Content
Novartis (NVS) Reports Positive Data on Ultibro Breezhaler
May 25 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close81.35
Today’s open80.86
Day’s range80.57 - 81.02
Volume1,735,434
Average volume (3 months)2,872,577
Market cap$190.6B
Dividend yield3.37%
Data as of 4:02pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)-61.91%
Earnings growth (this year)--
Earnings growth (next 5 years)+6.03%
Revenue growth (last year)-1.90%
P/E ratio30.3
Price/Sales3.61
Price/Book2.54

Competitors

 Today’s
change
Today’s
% change
PFEPfizer-0.02-0.06%
MRKMerck-0.12-0.18%
SNYSanofi-0.03-0.06%
ABBVAbbVie-0.26-0.39%
Data as of 4:02pm ET, 05/26/2017

Financials

Next reporting dateJuly 18, 2017
EPS forecast (this quarter)$1.19
Annual revenue (last year)$48.4B
Annual profit (last year)$6.7B
Net profit margin13.83%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Joseph Jimenez
Chief Financial Officer
Harry Kirsch
Corporate headquarters
Basel, Basel-stadt (basle Town)

Forecasts